Physician profile
Jacqueline Mcdaniel
NPI 1932280799
$15,497.71
in general payments reported to CMS, 2019-2025
15 companies · $2,054 in 2025
The $2,054 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $676 · 2022: $1,114 · 2023: $1,142 · 2024: $11K · 2025: $2,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,125 · Food and Beverage: $5,493 · Travel and Lodging: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,125.00 |
| Food and Beverage | $5,493.45 |
| Travel and Lodging | $1,089.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $10,777.31 | 2021-2025 | Biktarvy, Yeztugo, Sunlenca |
| Viiv Healthcare Company | $2,508.93 | 2021-2025 | Cabenuva, Dovato, Apretude |
| Merck Sharp & Dohme LLC | $649.84 | 2021-2025 | Pifeltro, Delstrigo, Dificid |
| Theratechnologies INC. | $352.67 | 2021-2025 | Egrifta, Trogarzo |
| Abbvie INC. | $330.53 | 2021-2025 | |
| Janssen Biotech, INC. | $193.46 | 2021-2023 | Symtuza |
| Exact Sciences Corporation | $186.08 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Janssen Products, LP | $168.99 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $108.80 | 2022-2024 | Austedo Xr, Austedo |
| Napo Pharmaceuticals INC | $68.62 | 2023-2024 | Mytesi |
| Lilly USA, LLC | $58.04 | 2021 | |
| Emd Serono, INC. | $37.00 | 2025 | |
| Vbi Vaccine (Delaware) INC. | $26.25 | 2022 | |
| Pfizer INC. | $15.69 | 2024 | |
| Janssen Scientific Affairs, LLC | $15.50 | 2023 | Symtuza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.